These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16988744)

  • 1. Angiotensin-converting enzyme inhibitors and renal failure in diabetes.
    Hiremath S; Zimmerman D; Knoll GA
    Kidney Int; 2006 Oct; 70(7):1377; author reply 1378. PubMed ID: 16988744
    [No Abstract]   [Full Text] [Related]  

  • 2. ACE inhibitor use and the long-term risk of renal failure in diabetics.
    Woo KT; Lau YK; Wong KS; Chan CM
    Kidney Int; 2006 Oct; 70(7):1376-7; author reply 1378. PubMed ID: 16988741
    [No Abstract]   [Full Text] [Related]  

  • 3. ACE inhibitor use and the increased long-term risk of renal failure in diabetes.
    Hamming I; Goor Hv; Navis GJ
    Kidney Int; 2006 Oct; 70(7):1377-8; author reply 1378. PubMed ID: 16988743
    [No Abstract]   [Full Text] [Related]  

  • 4. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 5. ACE-inhibitor use and the long-term risk of renal failure in diabetes.
    Suissa S; Hutchinson T; Brophy JM; Kezouh A
    Kidney Int; 2006 Mar; 69(5):913-9. PubMed ID: 16518351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best practice for hypertensive patients with kidney disease.
    de Zeeuw D
    Hosp Med; 2003 Feb; 64(2):96-100. PubMed ID: 12619337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microalbuminuria in diabetes mellitus.
    Tobe SW; McFarlane PA; Naimark DM
    CMAJ; 2002 Sep; 167(5):499-503. PubMed ID: 12240818
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetic nephropathy and renal protective agents.
    Marchiando R; Elston MP
    S D J Med; 1999 Oct; 52(10):385-6. PubMed ID: 10546516
    [No Abstract]   [Full Text] [Related]  

  • 9. Preserving the diabetic kidney.
    Poirier SJ
    J Fam Pract; 1998 Jan; 46(1):21-7. PubMed ID: 9451365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephropathy in patients with type 2 diabetes mellitus.
    Ritz E; Orth SR
    N Engl J Med; 1999 Oct; 341(15):1127-33. PubMed ID: 10511612
    [No Abstract]   [Full Text] [Related]  

  • 11. ACE inhibitors as a shield against diabetic nephropathy.
    Materson BJ
    Arch Intern Med; 1996 Feb; 156(3):239-40. PubMed ID: 8572832
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of diabetic nephropathy.
    Materson BJ; Preston RA
    Hosp Pract (1995); 1997 Feb; 32(2):129-34, 139-40. PubMed ID: 9040425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibitors and renoprotection.
    Peterson K
    J Fam Pract; 1996 May; 42(5):453. PubMed ID: 8642355
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renal complications of diabetes].
    Tielemans C
    Rev Med Brux; 1995; 16(4):258-61. PubMed ID: 7481238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of nephropathy and lipid disorders. Making progress while heeding Molière's warning.
    Bloomgarden ZT
    Diabetes Care; 1994 Aug; 17(8):946-8. PubMed ID: 7956651
    [No Abstract]   [Full Text] [Related]  

  • 16. Microalbuminuria as a target to improve cardiovascular and renal outcomes.
    Basi S; Lewis JB
    Am J Kidney Dis; 2006 Jun; 47(6):927-46. PubMed ID: 16731288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibitors: first line therapy in patients with diabetic hypertension?
    Levy EM
    Curr Opin Nephrol Hypertens; 1999 May; 8(3):333-4. PubMed ID: 10456264
    [No Abstract]   [Full Text] [Related]  

  • 19. Renoprotection in diabetes: genetic and non-genetic risk factors and treatment.
    Parving HH
    Diabetologia; 1998 Jul; 41(7):745-59. PubMed ID: 9686914
    [No Abstract]   [Full Text] [Related]  

  • 20. ACE inhibition in diabetic patients. Economic implications.
    Rodby RA; Lewis EJ
    Pharmacoeconomics; 1996 Oct; 10(4):315-20. PubMed ID: 10163576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.